Shareholders Lose Lawsuit Over Diabetes Drug Delay
A proposed class of shareholders who sued a biopharmaceutical company over an unexpected delay in the approval of a breakthrough diabetes drug lost their case Thursday when a New Jersey federal judge...To view the full article, register now.
Already a subscriber? Click here to view full article